-
DCGI extends shelf life of COVISHIELD: Document, sources
expresspharma
April 01, 2021
India’s drug regulator has allowed the AstraZeneca COVID-19 vaccine to be used for up to nine months from its manufacture date, as opposed to the prescribed six months, according to a document reviewed by Reuters.
-
Resumed clinical trials will grow gradually with COVID-19 vaccine rollout: GlobalData
expresspharma
March 31, 2021
With the expected decrease in monthly COVID-19 cases due to increasing vaccinations in countries such as the US and the UK, GlobalData expects clinical trials to resume more quickly in these countries.
-
COVID-19 vaccines from Pfizer, Moderna very effective after first shot: US real-world study
expresspharma
March 31, 2021
The risk of infection fell 90 per cent by two weeks after the second shot, the study of nearly 4,000 US healthcare personnel and first responders found.
-
GSK agrees to support manufacture of Novavax' COVID-19 vaccine
pharmatimes
March 30, 2021
GlaxoSmithKline (GSK) has agreed in principle to support manufacturing of up to 60 million doses of Novavax’ COVID-19 vaccine candidate – NVX-CoV2373 – for use in the UK.
-
BioNTech Provides Update on Vaccine Production Status at Marburg Manufacturing Site
americanpharmaceuticalreview
March 30, 2021
BioNTech announced the European Medicines Agency (EMA) approved the manufacturing of the COVID-19 vaccine drug product at the facility in Marburg. As part of the process, EMA has approved the production of the drug substance, the mRNA, at the Marburg ...
-
Moderna ships 100 millionth dose of its COVID-19 vaccine to US govt
expresspharma
March 30, 2021
Moderna announced that the company has shipped the 100-millionth dose of its COVID-19 vaccine to the US Government.
-
Jubilant, Novavax Enter COVID-19 Vaccine Partnership
contractpharma
March 30, 2021
Jubilant to provide fill-finish manufacturing services for the production of COVID-19 vaccine candidate NVX-CoV2373.
-
Johnson & Johnson Announces Advance Purchase Agreement with the African Vaccine Acquisition Task Team for the Company's COVID-19 Vaccine Candidate
prnasia
March 29, 2021
Janssen Pharmaceutica NV, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, has entered into an agreement with the African Vaccine Acquisition Task Team (AVATT) to make available up to 220 million doses of its single-shot COVID-19 ...
-
AstraZeneca confirms COVID-19 vaccine efficacy with primary analysis
europeanpharmaceuticalreview
March 29, 2021
Following DSMB concerns about the data released regarding the Phase III US trial, AstraZeneca has now confirmed that its vaccine is 76 percent effective against symptomatic COVID-19.
-
Russian President experienced slight side effects from COVID-19 vaccine: Reports
expresspharma
March 29, 2021
Putin did not reveal which of three Russian vaccines he had taken, saying only the doctor who inoculated him knows that.